Raffa Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.22K | Hold |
28
| – | – | ﹤0.01% | 807 |
|
|
2026
Q1 | $2.1K | Hold |
28
| – | – | ﹤0.01% | 737 |
|
|
2025
Q4 | $2.21K | Hold |
28
| – | – | ﹤0.01% | 716 |
|
|
2025
Q3 | $1.83K | Hold |
28
| – | – | ﹤0.01% | 736 |
|
|
2025
Q2 | $1.11K | Hold |
28
| – | – | ﹤0.01% | 842 |
|
|
2025
Q1 | $845 | Hold |
28
| – | – | ﹤0.01% | 870 |
|
|
2024
Q4 | $979 | Hold |
28
| – | – | ﹤0.01% | 874 |
|
|
2024
Q3 | $1.12K | Hold |
28
| – | – | ﹤0.01% | 821 |
|
|
2024
Q2 | $1.33K | Hold |
28
| – | – | ﹤0.01% | 818 |
|
|
2024
Q1 | $1.21K | Hold |
28
| – | – | ﹤0.01% | 846 |
|
|
2023
Q4 | $1.42K | Hold |
28
| – | – | ﹤0.01% | 717 |
|
|
2023
Q3 | $1.27K | Hold |
28
| – | – | ﹤0.01% | 715 |
|
|
2023
Q2 | $1.15K | Hold |
28
| – | – | ﹤0.01% | 758 |
|
|
2023
Q1 | $1K | Hold |
28
| – | – | ﹤0.01% | 786 |
|
|
2022
Q4 | $1.06K | Hold |
28
| – | – | ﹤0.01% | 764 |
|
|
2022
Q3 | $1.24K | Hold |
28
| – | – | ﹤0.01% | 731 |
|
|
2022
Q2 | $1.04K | Hold |
28
| – | – | ﹤0.01% | 807 |
|
|
2022
Q1 | $1.04K | Hold |
28
| – | – | ﹤0.01% | 848 |
|
|
2021
Q4 | $852 | Hold |
28
| – | – | ﹤0.01% | 928 |
|
|
2021
Q3 | $939 | Hold |
28
| – | – | ﹤0.01% | 840 |
|
|
2021
Q2 | $1.12K | Hold |
28
| – | – | ﹤0.01% | 788 |
|
|
2021
Q1 | $1.26K | Buy |
28
+10
| +56% | +$558 | ﹤0.01% | 763 |
|
|
2020
Q4 | $1.02K | Hold |
18
| – | – | ﹤0.01% | 741 |
|
|
2020
Q3 | $854 | Hold |
18
| – | – | ﹤0.01% | 718 |
|
|
2020
Q2 | $1.06K | Hold |
18
| – | – | ﹤0.01% | 648 |
|
|
2020
Q1 | $851 | Hold |
18
| – | – | ﹤0.01% | 638 |
|
|
2019
Q4 | $1.09K | Hold |
18
| – | – | ﹤0.01% | 595 |
|
|
2019
Q3 | $1.08K | Buy |
+18
| New | +$1.17K | ﹤0.01% | 569 |
|
|
2019
Q2 | – | Sell |
-18
| Closed | -$1.46K | – | 1045 |
|
|
2019
Q1 | $1.46K | Hold |
18
| – | – | ﹤0.01% | 426 |
|
|
2018
Q4 | $973 | Hold |
18
| – | – | ﹤0.01% | 546 |
|
|
2018
Q3 | $928 | Hold |
18
| – | – | ﹤0.01% | 651 |
|
|
2018
Q2 | $750 | Hold |
18
| – | – | ﹤0.01% | 702 |
|
|
2018
Q1 | $793 | Buy |
+18
| New | +$914 | ﹤0.01% | 690 |
|
|
2017
Q3 | – | Sell |
-29
| Closed | -$1.48K | – | 329 |
|
|
2017
Q2 | $1.48K | Hold |
29
| – | – | ﹤0.01% | 315 |
|
|
2017
Q1 | $1.17K | Hold |
29
| – | – | ﹤0.01% | 313 |
|
|
2016
Q4 | $1.39K | Hold |
29
| – | – | ﹤0.01% | 348 |
|
|
2016
Q3 | $1.06K | Hold |
29
| – | – | ﹤0.01% | 394 |
|
|
2016
Q2 | $675 | Hold |
29
| – | – | ﹤0.01% | 544 |
|
|
2016
Q1 | $1.18K | Hold |
29
| – | – | ﹤0.01% | 357 |
|
|
2015
Q4 | $1.8K | Buy |
+29
| New | +$1.56K | ﹤0.01% | 279 |
|
Other funds holding IONS
Raffa Wealth Management's IONS Position: Q2 2026 in Review
Raffa Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 28 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #807.
Raffa Wealth Management first reported a position in IONS in Q4 2015 and has held it in 40 quarters since. 477 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Raffa Wealth Management held 28 shares of Ionis Pharmaceuticals worth $2.22K as of Q2 2026.
- Raffa Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #807 holding.
- Raffa Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2015 and has held it in 40 quarters since.
- 477 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.